Olivia Newton-John Cancer Wellness and Research Centre

OrgUnit's Researchers
(Persons)

Results 1-5 of 45 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Berlangieri, AlexandraAlexandra.BERLANGIERI@austin.org.au
Berlangieri, Salvatore USam.Berlangieri@austin.org.au
Berry, ColleenColleen.BERRY@austin.org.au
Brown, KerrynKez.Brown@austin.org.au
Burgess, Adele NAdele.BURGESS@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 181-200 of 927 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
18110-Jun-2022Comprehensive review of hydrogel spacers prior to radiation therapy for prostate cancer.Harvey, Michael; Ong, Wee Loon ; Chao, Michael ; Udovicich, Cristian; McBride, Sean; Bolton, Damien M ; Eastham, James; Perera, Marlon 
182Mar-2023Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer.Harvey, Michael; Ong, Wee Loon ; Chao, Michael ; Udovicich, Cristian; McBride, Sean; Bolton, Damien M ; Eastham, James; Perera, Marlon 
18313-May-2022Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.Berthelet, Jean; Foroutan, Momeneh; Bhuva, Dharmesh D; Whitfield, Holly J; El-Saafin, Farrah; Cursons, Joseph; Serrano, Antonin; Merdas, Michal; Lim, Elgene; Charafe-Jauffret, Emmanuelle; Ginestier, Christophe; Ernst, Matthias ; Hollande, Frédéric; Anderson, Robin L ; Pal, Bhupinder; Yeo, Belinda ; Davis, Melissa J; Merino, Delphine
18430-Oct-2021Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.Wang, Michael T ; Ramchandren, Radhakrishnan; Chen, Robert; Karlin, Lionel; Chong, Geoffrey ; Jurczak, Wojciech; Wu, Ka Lung; Bishton, Mark; Collins, Graham P; Eliadis, Paul; Peyrade, Frédéric; Lee, Yihua; Eckert, Karl; Neuenburg, Jutta K; Tam, Constantine S
1852-Jul-2021Confronting behaviour in palliative care: a qualitative study of the lived experience of nursing staff.Pejoski, Natalie; Skaczkowski, Gemma ; Moran, Juli A ; Hodgson, Hilary; Wilson, Carlene J 
186May-2022Connection, courage and cancer: A diagnosis of lymphoma in the time of COVID.Gates, Priscilla 
187Aug-2020A consensus statement on the use of biosimilar medicines in hematology in Australia.Gregory, Gareth P; Carrington, Christine; Cheah, Chan Y; Hawkes, Eliza A ; Irving, Ian M; Siderov, Jim ; Opat, Stephen
1882022Consolidation nivolumab and ipilimumab versus observation in limited-disease small cell lung cancer after chemo-radiotherapy - Results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.Peters, S ; Pujol, J-L; Dafni, U; Dómine, M; Popat, S; Reck, M; Andrade, J; Becker, A; Moro-Sibilot, D; Curioni-Fontecedro, A; Molinier, O; Nackaerts, K; Mollá, A Insa; Gervais, R; Vivanco, G López; Madelaine, J; Mazieres, J; Faehling, M; Griesinger, F; Majem, M; Larriba, J L González; Pulla, M Provencio; Vervita, K; Roschitzki-Voser, H; Ruepp, B; Mitchell, Paul L R ; Stahel, R A; Le Pechoux, C; De Ruysscher, D
189Oct-2019Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature.Ong, Wee Loon ; Wada, Morikatsu ; Ruben, Jeremy; Foroudi, Farshad ; Millar, Jeremy
19011-Oct-2018Correction to: Differences in cancer survival by sex: a population-based study using cancer registry data.Afshar, Nina; English, Dallas R; Thursfield, Vicky; Mitchell, Paul L R ; Te Marvelde, Luc; Farrugia, Helen; Giles, Graham G; Milne, Roger L
19118-Sep-2021Correction to: Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-study.Gates, Priscilla ; Dhillon, Haryana; Gough, Karla; Wilson, Carlene J ; Hawkes, Eliza A ; Scudder, Lindsay; Cushion, Tania; Krishnasamy, Meinir
1928-Sep-2021Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.Murali, Krithika; Dwarte, Tanya M; Nikfarjam, Mehrdad ; Tucker, Katherine M; Vaughan, Rhys B ; Efthymiou, Marios ; Collins, Allison L ; Spigelman, Allan D; Salmon, Lucinda ; Johns, Amber L; Williams, David B; Delatycki, Martin B ; John, Thomas ; Stoita, Alina
19315-Jun-2021Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.Arulananda, Surein; O'Brien, Megan; Evangelista, Marco; Harris, Tiffany J ; Steinohrt, Nikita S; Jenkins, Laura J; Walkiewicz, Marzena; O'Donoghue, Robert J J; Poh, Ashleigh R; Thapa, Bibhusal ; Williams, David S ; Leong, Trishe; Mariadason, John M ; Li, Xia; Cebon, Jonathan S ; Lee, Erinna F; John, Thomas ; Fairlie, Walter Douglas 
194Feb-2022Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.Lickliter, Jason D; Voskoboynik, Mark; Mileshkin, Linda; Gan, Hui K ; Kichenadasse, Ganessan; Zhang, Kathy; Zhang, Maggie; Tang, Zhiyu; Millward, Michael
19522-Aug-2022Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K 
19617-Jun-2022Correlating measured radiotherapy dose with patterns of endocrinopathy: The importance of minimising pituitary dose.Fraser, Olivia; Crowne, Elizabeth; Tacey, Mark A ; Cramer, Rebecca; Cameron, Alison
19717-Mar-2015Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.Price, Timothy J; Bruhn, M A; Lee, C K; Hardingham, J E; Townsend, A R; Mann, K P; Simes, J; Weickhardt, A ; Wrin, J W; Wilson, K; Gebski, V; Van Hazel, G; Robinson, B; Cunningham, D; Tebbutt, Niall C 
1981-Mar-2006Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.Cher, Lawrence M ; Murone, Carmel ; Lawrentschuk, Nathan; Ramdave, Shanker; Papenfuss, Anthony; Hannah, Anthony; O'Keefe, Graeme J; Sachinidis, John I; Berlangieri, Salvatore U ; Fabinyi, Gavin C ; Scott, Andrew M 
199Oct-2018Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis.Chua, Chong Chyn ; Omerod, Amanda; Wight, Joel C ; Juneja, Surender; Zantomio, Daniela 
20028-Sep-2023Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.Margalit, Ofer; Harmsen, William S; Shacham-Shmueli, Einat; Voss, Molly M; Boursi, Ben; Wagner, Anna D; Cohen, Romain; Olswold, Curtis L; Saltz, Leonard B; Goldstein, Daniel A; Hurwitz, Herbert; Tebbutt, Niall C ; Kabbinavar, Fairooz F; Adams, Richard A; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef